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Dendritic cells (DCs) and complement are both key members of the innate and adaptive
immune response. Recent experimental mouse models have shown that production of
alternative pathway (AP) components by DCs strongly affects their ability to activate and
regulate T-cell responses. In this study we investigated the production and regulation of
properdin (fP) and factor H (fH) both integral regulators of the AP, by DCs and tolerogenic
DCs (tolDCs). Both fP and fH were produced by DCs, with significantly higher levels of
both AP components produced by tolDCs. Upon activation with IFN-γ both cells increased
fH production, while simultaneously decreasing production of fP. IL-27, a member of
the IL-12 family, increased fH, but production of fP remained unaffected. The functional
capacity of fP and fH produced by DCs and tolDCs was confirmed by their ability to bind
C3b. Inhibition of fH production by DCs resulted in a greater ability to induce allogenic
CD4+ T-cell proliferation. In contrast, inhibition of fP production led to a significantly
reduced allostimulatory capacity. In summary, this study shows that production of fP
and fH by DCs, differentially regulates their immunogenicity, and that the local cytokine
environment can profoundly affect the production of fP and fH.
Keywords: Complement  Cytokines  Factor H  IFN-γ  IL-27  Properdin  Tolerogenic
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Introduction
Dendritic cells (DCs) and the complement system are both inte-
gral members of the immune system participating in the first line
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of defence of the innate immune response and together further
tailoring our adaptive immune response [1–3]. The complement
system is composed of three distinct pathways-classical, lectin and
alternative. Together these pathways serve as key mediators of
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the innate immune response, involved in defending the host from
pathogens, removing immune complexes and facilitating efficient
phagocytosis of apoptotic cells [2, 4]. A key role of complement
in the humoral arm of the adaptive immune response has been
demonstrated through experimental depletion of complement,
resulting in poorer antibody responses. Furthermore opsoniza-
tion with complement fragments profoundly lowers the amount
of antigen needed to induce antibody production [5, 6]. Recently,
there has been an increasing body of evidence demonstrating that
complement may function more broadly as a link between innate
and adaptive immunity. This includes murine studies which have
demonstrated a role for the AP in the DC: T-cell synapse [3, 7–9].
Both APC and T-cells have been shown to increase C3a and C5a
receptor on their surface [10], while a surface regulator, decay
accelerating factor, has been shown to be decreased, allowing for
further complement activation [11, 12].
The AP is unique in that it can become auto activated via C3
hydrolysis generating a C3b like molecule which can bind cova-
lently to an activating surface recruiting factor B, which is then
cleaved by factor D generating a C3 convertase (C3bBb). This
C3 convertase can convert further C3 to C3b, with stabilization
of the enzyme by properdin (fP) allowing for propagation of the
AP activation [13]. Regulation of the AP is key, with fP promot-
ing AP activation and negative regulators such as factor H (fH),
limiting the availability of C3b, or acting as a cofactor for factor I,
which degrades C3b. This delicate balance between activators and
inhibitors of the AP is crucial for controlling complement activa-
tion [14]. The majority of complement proteins are produced by
the liver, although white blood cells including DCs can also act as a
local source of certain complement proteins [15]. The source of fP
is largely restricted to white cells, including neutrophils [16, 17].
fH is most abundantly expressed in the liver, but also here extra
hepatic production has been described, which includes mesan-
gial cells, endothelial cells, and fibroblasts [18–21]. This suggests
that local cell populations, either resident or infiltrating, can sig-
nificantly contribute to the overall complement activation at a
particular site of inflammation.
DCs are distinct among other cells in the immune system as they
are uniquely equipped to respond to a host of innate stimuli while
also adapting and tailoring their functions in response to the local
cytokine environment. This had led to the understanding that DCs
are not just immunogenic but that tolerogenic DCs (tolDCs) also
exist. These tolDCs are characterized by differences in cytokine
production and expression of co-stimulatory molecules, which has
a direct impact on the strength and quality of their T-cell stimu-
latory capacities [22, 23]. Previous studies have demonstrated by
RT-PCR that DCs can express many components of the comple-
ment system [24, 25], however protein data to support this has
been limited. Furthermore there are only limited data available on
the regulation of AP component production by DCs or particularly
tolDC populations. Local production of complement components
such as C3 by APCs at the site of inflammation or immunolog-
ical synapse can be instrumental in the immune response [8].
With the demonstration that local AP activation at the interface
of APC and T cells plays a key role in the regulation of T-cell
responses [26], regulation of the AP in the local environment will
be key in controlling the strength of the T-cell response. Therefore,
we investigated the regulation of two integral modulating factors
of the AP, fP, and fH. Combined both molecules have the ability
to influence the balance of the AP toward activation or regulation.
In this study, we demonstrate that DCs are a source of fP and
fH and that tolDCs are superior producers of both components.
We observed a differential regulation of fP and fH, whereby IFN-γ
profoundly inhibited fP in both cell types, while simultaneously
increasing production of fH. This distinct dual effect was found
to be unique for type II IFN. IL-27 is a member of the IL-12 fam-
ily, which demonstrates some functional homogeny with IFN-γ in
human dendritic cells and hepatocytes [27–29]. In line with this
functional homogeny with IFN-γ, IL-27 did significantly enhance
fH levels in DC supernatants. Importantly, RNA interference of
fH in DCs increased their allostimulatory capacity, while siRNA
targeting of fP decreased T-cell proliferation. Taken together, our
data suggest that the local cellular and cytokine microenvironment
are crucial for overall complement regulation and thereby T-cell
immunity.
Results
TolDCs display elevated levels of properdin and fH
Monocyte derived DCs and tolDCs were generated as previously
described [30–32]. Flow cytometric analysis revealed that DCs
display characteristic features, expressing high levels of DC-SIGN
but little or no expression of CD14. In contrast, although tolDC
display similar levels of DC-SIGN, they maintain their expression
of CD14 upon differentiation from monocyte to DC (Fig. 1A).
Both cell types were stimulated with IFN-γ or LPS and assessed
for IL-12 and IL-10 production. DCs produced significant levels
of IL-12 upon stimulation while IL-10 was relatively low. In con-
trast tolDCs demonstrated a typical profile with absence of IL-
12 and high IL-10 production (Fig. 1B and C). In addition these
tolDCs had a poor ability to stimulate allogenic T-cell proliferation
(Fig. 1D).
To investigate the contribution of DCs to the production of
alternative pathway related proteins we first assessed by RT-PCR
if CFP and CFH were expressed in both DC and tolDC populations.
We demonstrate that DCs and tolDCs expressed both factors, and
that tolDCs showed more than 10 fold higher transcription of both
CFP and CFH compared to DCs (Fig. 2A and B). IFN-γ stimulation
of tolDCs resulted in lower mRNA expression of CFP as compared
to the unstimulated state, although not statistically significant a
similar trend was observed in DCs. In contrast, DCs and tolDCs
stimulated with IFN-γ or LPS demonstrated no significant overall
change in CFH expression (Fig. 2A and B).
We assessed fP and fH protein production within DCs and
tolDCs using intracellular microscopy. Using this method we could
demonstrate expression of fP and fH protein in both DCs and
tolDCs (Fig. 2C). Incubation with IFN-γ reduced the presence of
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Figure 1. Characterization of DCs and
tolDCs. Monocytes were isolated from
PBMCs and DCs were generated by cultur-
ing in medium supplemented with GM-CSF
and IL-4. TolDCs were generated by addi-
tion of dexamethasone (Dex) only at the
start of culture (day 0). (A) Representative
histograms of cell surface FACS analysis on
DC and tolDC at day 6 of culture, stained for
CD14 and DC-SIGN. Histograms shown were
gated on PI negative cells, dashed lines rep-
resent isotype control mAb staining. Results
shown are from a representative exper-
iment of three independent experiments
performed with three different donor sam-
ples. Cells were stimulated with IFN-γ or LPS
and the supernatants were harvested and
(B) IL-12p40 and (C) IL-10 was measured by
ELISA. Data are shown as mean + SD and
are pooled from four independent exper-
iments performed with 4 different donor
samples. (D) DCs were co-cultured with
CFSE labeled allogenic CD4+ T cells at a ratio
of 1:10. On day 5 the T cells were harvested
and the CFSE staining was analyzed using
flow cytometry. Data shown is representa-
tive of three independent experiments per-
formed with three different donor samples.
fP, which is in line with our findings at mRNA level. In contrast to
fP, IFN-γ appeared to increase the expression of fH.
IFN-γ exerts opposing effects on the production of fP
and fH by DCs and tolDCs
To further assess the regulation of fP and fH protein, we per-
formed ELISAs on cell culture supernatants. In line with Q-PCR
data (Fig. 2), we found that tolDCs produced significantly more
fP and fH compared to DCs (Fig. 3A and D). For comparison,
supernatants from neutrophils, a widely accepted source of fP,
were shown to produce levels of fP similar to DCs, but with only
minimal production of fH. To investigate whether the differential
regulation of fP and fH was a general feature of mature DCs or was
activation dependent, we compared stimulation with either IFN-γ
or LPS. In view of the large differences in fP and fH production
(Fig. 3A and D), we calculated the relative change upon stimula-
tion for each donor measured, with the immature/medium state
set at 100%. In both DC and tolDC we observed that fP production
was significantly reduced in the presence of IFN-γ (Fig. 3B and C).
Regulation of fH demonstrated the opposite effect, where both cell
types showed a significant increase in fH production upon treat-
ment with IFN-γ (Fig. 3E and F). Despite the strong induction of
cytokine production (Fig. 1), LPS did not show a significant effect
on the production of either fP or fH.
Type I IFNs do not possess the opposing properties of
IFN-γ, while IL-27 specifically increases fH
We addressed whether other members of the Interferon family, or
IL-27, could also possess this dual role in regulating alternative
pathway components in DCs. Similar to IFN-γ stimulation IFN-α,
but not IFN-β, did significantly reduce fP levels in tolDC super-
natants. No regulation of fP was observed in DC treated with type
C© 2017 The Authors. European Journal of Immunology published by
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Figure 2. Expression and production of properdin and fH by human DCs and tolDCs. Dendritic cells were harvested after 6 days of culture, washed
and stimulated with IFN-γ or LPS, after which mRNA was isolated followed by cDNA synthesis. The transcript levels of (A) Properdin (CFP) (B)
Factor H (CFH) were determined by RT-PCR. GAPDH mRNA expression from the same samples was used as an endogenous reference gene (relative
mRNA expression). Data are shown is mean + SD of 8 independent experiments performed with eight different donor samples.* one-tailed t-test
p0.047,**p0.082 (C) DCs were cultured on 8-well chamber slides and either untreated or stimulated with IFN-γ followed by incubation with
Brefeldin. The cells were then fixed and permeabilized, followed by incubation with anti-fP or anti-fH followed by detection with GaM-Alexa488.
Fluorecent images are from a single experiment representative of experiments performed with three different donor samples. Scale bar 25 μm.
I IFN (Fig. 4A and C). In contrast, IL-27 did not demonstrate any
clear ability to regulate fP production. The levels of fH remained
unchanged in both DC and tolDCs stimulated with either IFN-α
or IFN-β but were significantly upregulated upon IL-27 and IFN-γ
stimulation respectively (Fig. 4B and D).
DC-derived fP and fH exhibit traditional functional
characteristics
We assessed whether fH found in DC supernatants can bind to
C3b, a key characteristic of serum derived fH. Although we found
Figure 3. IFN-γ exerts opposing effects on the production of fP and fH by DC and tolDC. DCs were harvested on day 6, and neutrophils were
isolated from blood as described in the Materials and methods, followed by replating for another 24 h. (A) fP and (D) fH production was measured
using ELISA. Data shown is mean ± SD of 8–24 (fP) or 4–18 (fH) independent experiments which were pooled together. Cells were stimulated
for 24 h after which (B, C) fP and (E, F) fH was determined by ELISA. Levels upon stimulation were expressed as percentage change relative to
unstimulated conditions of the same donor (relative change). Data shown is mean ± SD of 9–28 independent experiments which were pooled
together, one-tailed t-test ***p0.0001.
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Figure 4. Type I IFNs decrease fP produc-
tion but do not increase fH, while IL-27
specifically increases fH. Dendritic cells
were harvested after 6 days of culture and
stimulated with IFN-γ, IFN-β, IFN-α, or IL-
27. Supernatants were harvested after 48
h the and (A, C) fP and (B, D) fH was mea-
sured by sandwich ELISA. Data shown is
the mean ±SD of 8–13 independent exper-
iments pooled together, one-tailed t-test
*p0.04, ***p0.0016.
minimal binding using supernatants of immature DC, the binding
was enhanced in the supernatants from IFN-γ-stimulated DCs. This
binding was more pronounced in supernatants of IFN-γ-stimulated
tolDCs (Fig. 5A). We assessed the ability of fP derived from DCs
and tolDCs to bind its traditional ligand C3b and found that while
the amount produced by DCs might be too little for detection, fP
derived from tolDCs showed a strong and dose-dependent binding
to C3b (Fig. 5B). To confirm the specificity of this assay we show
that binding is inhibited upon depletion of fP using pre-coupled
anti-properdin beads (Fig. 5C).
Recently it has been shown that fP possesses additional func-
tions aside from C3b binding, and may act as an indepen-
dent recognition molecule for necrotic and apoptotic cells [33].
Necrotic cells were generated as previously described [30], and
incubated with conditioned supernatant of DC or tolDC, followed
by detection of fP binding. Using fluorescent microscopy, fP bind-
ing was detected on necrotic cells exposed to DC supernatant and
this binding was even more evident on necrotic cells exposed to
tolDC supernatants (Fig. 5D). This binding to necrotic cells was
confirmed by flow cytometric analysis (Fig. 5E), and quantifica-
tion across multiple donors showed that supernatants of tolDC
demonstrated significantly higher levels of fP binding to necrotic
cells compared to supernatant of DCs (Fig. 5F).
Inhibition of fP in DC reduces T-cell proliferation,
while inhibition of fH enhances proliferation
In light of the recent evidence that AP components may play a role
in the allostimulatory capacity of DCs [8, 34], we investigated
whether silencing of fP or fH in human DCs could alter T-cell
activation in an allogenic setting. We successfully and specifically
silenced fP and fH in both immature and IFN-γ-stimulated DCs by
up to 60% on average (Fig. 6A and F). Cells treated with siRNA
were harvested and co cultured with allogenic total CD4+ T-cells
at indicated ratios for 5 days. Proliferation was determined by
3[H]-thymidine incorporation. We observed that silencing of fP in
DCs significantly hampered their ability to induce allogenic T-cell
proliferation compared with DCs with non-targeted siRNA (Fig.
6B). This inhibition of proliferation was even more pronounced
when fP silencing was combined with IFN-γ stimulation (Fig. 6C).
The silencing procedure by itself did not affect the T-cell stimula-
tory capacity and the reduced proliferation upon fP silencing was
significant for different individual experiments (Fig. 6D). In these
co-cultures, IFN-γ production was relatively low, but showed a
trend for reduced production in IFN-γ-activated, fP-silenced DC
(Fig. 6E).
Similar experiments were performed using DCs treated with
siRNA targeting fH. These cells induced significantly more T-cell
proliferation compared to non-target (non) treated DCs (Fig. 6G).
This was also observed, but to a lesser degree, with DCs acti-
vated with IFN-γ (Fig. 6H). Both immature and IFN-γ-stimulated
DCs silenced for fH exhibited more T-cell proliferation, in par-
ticular at a ratio of 1:40 (Fig. 6I). We assessed the production
of IFN-γ in T-cell supernatants and found that immature DCs
silenced for fH induced more IFN-γ production. In line with
our proliferation data the stimulatory effect of silencing fH was
less potent when the DCs were first activated with IFN-γ (Fig.
6J). Taken together loss of fH induced more T-cell proliferation
while loss of fP decreased T-cell proliferation, suggesting that the
local complement activation is important in regulating DC: T-cell
responses.
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Figure 5. DC derived fP and fH exhibit traditional functional characteristics. Dendritic cells were harvested after 6 days of culture and either
untreated or stimulated with IFN-γ. After 48 h the supernatants were harvested and incubated on ELISA plate coated with C3b, followed by
detection of (A) fH and (B) fP. (C) To determine the specificity of fP binding the same C3b binding assay was performed with tolDCs supernatants
either untreated or depleted of fP using pre-coupled anti-properdin beads. Data shown is representative of three independent experiments
performed with three different donors. (D) Necrotic cells were generated and incubated with 48-h supernatants from immature DC/tolDC, followed
by detection of fP binding by fluorescent microscopy. Scale bars 25 μm. (F) The same experiment was performed followed by detection of fP binding
by flow cytometry. Relative binding refers to DC/tolDC conditioned medium relative cell free medium where cell free medium was set as 1. Data
shown is the mean ±SD of three independent experiments pooled together, one-tailed t-test *p0.0357.
Discussion
Dendritic cells are a heterogeneous population of professional
antigen presenting cells responsible for both the initiation of
immunity and immunological tolerance. Recent murine studies
have suggested that complement activation is a key determinant
in the ability of APCs to direct T-cell responses. In this study we
show that production of fP and fH by DCs is subject to regulation
by IFN-γ and IL-27 and that modulation of these regulators of
the AP determines the potency of the T-cell response. This impli-
cates the local cellular and cytokine microenvironment as crucial
mediators of overall complement regulation and subsequent T-cell
activation.
Several exciting studies over the last decade have introduced
complement as a system that actively plays a role in regulat-
ing T-cell immunity [3, 35]. By generating bone marrow APCs
from C3−/− [9, 36], factor B−/−, factor D−/−, C3aR−/− [37] and
C5aR−/− [38] mice, various groups demonstrated that DCs require
local complement activation in order to become fully competent
APCs. To date these studies have mainly focused on rodent mod-
els, however DCs from C3 deficient individuals [39] were also
shown to have impaired DC differentiation. More recently, a role
of C3a and C5a derived from human DC in T-cell proliferation has
been demonstrated in vitro and in a humanized mouse model [8].
Further work on human DCs and the contribution of other com-
plement factors has remained finite with mostly transcriptional
analysis and limited protein data.
We focused on monocyte-derived DCs and tolerogenic DCs and
showed that both cells produced fP and fH in an immature state
with tolDCs expressing much higher levels of both components.
Some studies have demonstrated gene expression of fP and fH in
plasmacytoid DCs [24]. Although we did not perform PCR analysis
on pDCs, we did test cellular supernatants and did not find any
detectable levels of both components analysed in this study (data
not shown).
Several complement components have been shown to possess
GAS and ISRE elements in their promoters [40, 41], so we assessed
the ability of IFN-γ to regulate fP and fH. Interestingly, IFN-γ pos-
sessed opposing roles by decreasing fP production, while increas-
ing fH. Decrease of fP upon IFN-γ stimulation has been observed
in primary monocytes and THP-1 cell lines [42], but to our knowl-
edge this is the first report of this dual effect on fH and fP in
human DCs. IFN-γ is the only member of the type II IFNs, so we
questioned whether the regulation of fP and fH was unique for
this specific member, or was a broader feature of the IFN fam-
ily, including type I IFNs. IFN-α and IFN-β behaved comparably
in terms of fP and fH regulation and did not possess the same
regulatory properties of IFN-γ.
The IL-12 family has been gaining attention as a key regulator
of immunity and immunological tolerance [43, 44], and one family
C© 2017 The Authors. European Journal of Immunology published by
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Figure 6. Inhibition of fP in DCs decreases the allostimulatory capacity of DCs while inhibition of fH enhances allogenic T-cell proliferation. DCs
were either non treated, or treated with siRNA targeting fP or non-specific (non) target. After 24 h of culture, with or without IFN-γ activation,
supernatants were harvested and fP was measured by ELISA (A). DCs with either fP or control silencing, without (B) or with IFN-γ (C) stimulation
were co-cultured with allogenic CD4+ T cells at indicated ratios. T-cell proliferation was determined at day 5 of culture by 3[H] incorporation. Data
shown are the mean ±SD of triplicate cultures. The mean ±SD of proliferation (D) and IFN-γ production (E) at the 1:40 ratio of three independent
experiments of cells silenced for fP is shown. DCs were either non treated, or treated with siRNA targeting fH or non-specific (non) target. After 24 h
of culture, with or without IFN-γ activation, supernatants were harvested and fH was measured by ELISA (F). DCs with either fH or control silencing,
without (G) or with IFN-γ (H) stimulation were co-cultured with allogenic CD4+ T cells at indicated ratios. T-cell proliferation was determined at
day 5 of culture by 3[H] incorporation. Data shown are the mean ±SD of triplicate cultures. The mean ±SD of proliferation (I) and IFN-γ production
(J) at the 1:40 ratio of three independent experiments of cells silenced for fH is shown. Data shown is the mean ±SD of 3 independent experiments
pooled together, one-tailed t-test *p0.02, ***p0.0001.
member, IL-27 has been shown to exert some functions typically
seen with IFN-γ stimulation [27, 28, 45, 46]. Interestingly IL-
27 stimulation of DCs did increase production of fH but did not
influence fP production again stressing the uniqueness of IFN-γ in
its differential regulation of these two opposing molecules of the
complement system.
Functionally both fP and fH were active in the traditional com-
plement assessment by binding to C3b. In recent years fP has been
shown to act as a recognition molecule [13, 33, 47] with the ability
to bind to, among others, apoptotic [48] and necrotic cells [49].
We found that fP from DCs could bind necrotic cells though we did
not test whether this was independent of complement activation.
We have shown that cytokines can profoundly and differen-
tially regulate the opposing regulators of the AP, fP, and fH.
IFN-γ stimulation of DCs also changes many phenotypical features
of DCs including up regulating co-stimulatory molecules such as
CD80 and CD86. In order to establish whether simply shifting the
balance of production of fP and fH could alter the allostimulatory
capabilities of DCs we silenced fP or fH in DCs and co-cultured
these cells with allogenic CD4+ T-cells. We found that inhibition
C© 2017 The Authors. European Journal of Immunology published by
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of fH led to a significant increase in T-cell proliferation while inhi-
bition of fP led to decreased proliferation. DCs silenced for fP and
activated with IFN-γ were even further hampered in their allostim-
ulatory capacity, likely because of the combined silenced by siRNA
and decreased fP production by IFN-γ.
The observation made with the local production and regulation
of soluble regulators of complement activation are in line with the
results obtained with the role of DAF in local C3 regulation and its
role in regulating T-cell responses [11]. DAF is a membrane bound
regulator, expressed both on T cells and APC, and presence of DAF
results in a reduced half-life of the C3 convertase. This activity is
similar to the activity of fH, and both will result in a reduced C3
activation. The model explaining the role of DAF, has shown that
a transient decrease of DAF on both T-cells and APC is required
to allow efficient T-cell activation [7, 11]. We confirmed that DAF
is expressed on human DC and found that expression is higher on
tolDC. However, at variance with fH, the expression of DAF was
not affected by IFN-γ stimulation (data not shown). Whereas both
DAF and fH are increased on tolDC, it is an oversimplification to
directly link this to the tolerogenic potential of these cells. First
of all, tolDC also express increased amounts of properdin, a posi-
tive regulator of the C3 activation which prolongs the half-life of
the convertase, and therefore the net results remains to be deter-
mined. Moreover, tolDC display a strongly increased expression
of tolerogenic molecules (IL-10, B7-H1) with simultaneous reduc-
tion of immunogenic factors (IL-12, CD80/CD86). Further work is
needed to fully establish whether the diverging T-cell proliferation
is a direct effect of fP and fH on the T-cells or a consequence of
altered local complement activation. Interestingly it has recently
been demonstrated that exogenous fH can generate a regulatory
state in DCs [50]. In line with these findings we have observed
inhibition of T-cell proliferation with increasing concentrations of
fH (Supporting Information Fig 2.), therefore it will be of special
interest to further investigate the effect on differentiation of func-
tional T helper subsets, in line with data in mice concerning the
role of C3a and C5a signalling in T helper differentiation [26, 34].
Taken together our results demonstrate a novel role for fP and
fH production by DCs to be a key regulator of T-cell activation.
Both molecules can be influenced by IFN-γ whereas only fH is
increased by IL-27, indicating that the local cellular and cytokine
environment can potentially influence the local complement acti-
vation and in turn local T-cell responses.
Materials and methods
Cell culture and reagents
Human monocytes were isolated from buffy coats obtained from
healthy donors using Ficoll density gradient centrifugation fol-
lowed by positive selection using anti-CD14 MACS microbeads
(Miltenyi Biotech GmBH, Bergisch Gladbach, Germany). DCs were
generated and cultured in RPMI 1640 supplemented with 10%
heat inactivated fetal calf serum (FCS), 90 U/mL penicillin, and
90 μg/mL streptomycin (Gibco/Life technologies, Breda, The
Netherlands), 5 ng/mL GM-CSF and 10 ng/mL IL-4 (Biosource
Europe, Belgium), as described before. Tolerogenic DC (tolDCs)
were generated by addition of Dexamethasone (10−6M Dex)
(Pharmacy, L.U.M.C., Leiden, the Netherlands) only at the start of
culture (day 0) [32]. Cultures were refreshed with medium con-
taining cytokines on day 3. For stimulation experiments, immature
DCs were harvested on day 6, washed, and seeded accordingly,
followed by addition of 200 ng/mL LPS (E.Coli EH100 Enzo, Bel-
gium), 100 ng/mL each of IFN-γ, IFN-α, IFN-β (Peprotech) or
100 ng/mL IL-27 (R&D). Neutrophils were isolated as previously
described [51]. Briefly, blood from healthy donors was collected
using ACD tubes (BD Vacutainer) and neutrophils were isolated
by Ficoll-Paque and Dextran T-500 gradients (Sigma Aldrich). The
preparation contained greater than 90% neutrophils as confirmed
by flow cytometry using CD16 (R&D Systems), CD11b (BD Bio-
sciences), and CD66b (AbD Serotec) antibodies.
Flow cytometry
For cell surface flow cytometric analysis, cells were harvested,
washed, and stained for 30 min at 4°C in FACS buffer (PBS, 0.5%
heat inactivated NHS, 1% BSA, 0.02% NaN3) with anti-CD14 M
P9 (BD Biosciences, San Diego, CA, USA) or anti-DC-SIGN (R&D
Systems, Wiesbaden, Germany). Non-conjugated antibodies were
detected with PE-conjugated goat-anti-mouse Ig (Dako, Glostrup,
Denmark). Isotype matched control antibodies were used to deter-
mine the level of background staining. The fluorescence was mea-
sured on an FACS Calibur flow cytometer, and data were analyzed
with Cell Quest Software (BD Biosciences, San Diego, CA, USA)
and FlowJo Software (Tree Star, USA).
mRNA isolation, cDNA synthesis, and RT-PCR
Cells were harvested and mRNA was isolated from DCs using an
Rneasy kit according to the manufacturer’s instructions (Qiagen,
Hilden, Germany). DNA was digested using the on-column RNase-
free DNase set. cDNA was synthesized using a reverse transcrip-
tion system kit (Promega) following the manufacturer’s guidelines
and stored at −20°C until analysis. Specific primers for human
Properdin (CFP), Factor H (CFH), and GAPDH (Table 1) were
designed using the computer software Oligo explorer and synthe-
sized at Biolegio. Primer specificity was tested by homology search
with the human genome (basic local alignment search tool or
BLAST; National Center for Biotechnology Information) and later
confirmed by electrophoresis through 2% agarose gels contain-
ing ethidium bromide followed by visualization under UV light.
GAPDH was used as an endogenous reference gene. For each sam-
ple, the relative abundance of target mRNA was calculated from
the obtained Ct values for the target gene and expressed relative
to the endogenous reference gene GAPDH. A table demonstrat-
ing the range of CT values for fP and fH expression is included
(Supporting Information Table 1).
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Table 1. Real-time PCR oligonucleotide sequences
Gene NCBI ID Protein ID Forward sequence Reverse sequence
CFP 5199 Proper din GTAATCACCCTGCTCCCAAG TTGCGGCTTCGTGTCTCC
CFH 3075 fH GCACACAAGATGGATGGTCG GGTCTGCGCTTTTGGAAGAG
GAPDH 2597 GAPDH TTCCAGGAGCGAGATCCCT CACCCATGACGAACATGGG
DC-T-cell co culture
Allogeneic CD4+ T-cells were isolated from buffy coats by nega-
tive selection using the MACS CD4+ T-Cell Isolation Kit II (Mil-
tenyi Biotec). DCs from all conditions were harvested after 24 h,
washed, and plated in 96-well round bottom plates at a starting
ratio of 1:40 with 100 000 T cells/well. Cells were cultured for
5 days and supernatant was harvested to measure IFN-γ produc-
tion by means of ELISA. Proliferation was assessed by the addition
of 3[H]-thymidine (0,5 μCi/well) [32]. Concerning experiments
with addition of exogenous fP and fH (Supporting Information
Fig. 2), total CD4+ T-cells were stimulated with allogenic DCs
and cultured with increasing concentrations of fP or fH. The cells
were cultured for 5 days after which proliferation was assessed by
the addition of 3[H]-thymidine (0,5 μCi/well). For DC character-
ization experiments, T cells were labeled with carboxyfluorescein
diacetate succinamidyl ester (CFSE) (Molecular Probes, Europe
BV Leiden, The Netherlands). In short, T cells were suspended
in PBS and incubated for 15 min at 37°C with 5 μM CFSE. The
reaction was quenched by washing the cells in medium containing
10% FCS before resuspending at 1 × 106/mL in total RPMI culture
medium. Labelled CD4+ T-cells were co-cultured with allogeneic
DCs/tolDCs at a 10:1 T-cell/DC ratio for 5 days. The T-cells were
then harvested and proliferation was assessed by CFSE dilution.
Confocal microscopy
Cells were cultured on 8-well chamber slides (Nunc) and stimu-
lated overnight with IFN-γ followed by Brefeldin-A for the last 5 h
of culture. The slides were subsequently washed and fixed in PBS
containing 4% formaldehyde, 1% heat inactivated FCS followed
by washing with PBS containing 1% BSA and permeabilized with
perm buffer (PBS, 0.5 % saponin, 0.1% BSA) for 10 min. The DCs
were then stained using purified anti-fP or anti-fH followed by
goat anti-mouse-Alexa 488. Hoechst was used for nuclear stain-
ing. Stains were visualized using Leica TCS SP5 or Zeiss LSM710
NLO.
Complement binding assays
For determination of properdin function, necrotic cells were
exposed to supernatant of DC or tolDC for 1 h at 4°C, followed
by detection of properdin binding by microscopy and flow cytom-
etry. Necrosis was induced by incubating Jurkat cells at 56°C in a
water bath for 1 h. And necrotic cells were confirmed by double-
staining with fluorescein isothiocyanate (FITC)–labeled annexin V
and Propidium Iodide (PI)(VPS Diagnostics, Hoeven, The Nether-
lands) according to established methods [52]. Cells were only
used if a purity of >70% was achieved i.e. >70% AnnV+, PI+.
The fluorescence was measured on an FACS Calibur flow cytome-
ter, and data were analyzed with Flow Jo and Cell Quest Software.
Purified human C3b [53], was coated overnight on a 96-well Nunc
plate followed by exposure to DC or tolDC supernatants and detec-
tion of properdin binding with rabbit anti human fP. To determine
specificity of the assay, tolDC sups were fP depleted by incubat-
ing with anti-properdin pre-coupled A/G beads overnight at 4°C.
Both depleted and control non-depleted tolDC supernatant was
assessed for ability to bind C3b as above. For determination of fH
binding, DCs were either unstimulated or stimulated with IFN-γ
prior to supernatant exposure to coated human C3b, followed by
detection by mouse anti factor H (Abcam).
Cytokine and complement production
DCs or neutrophils were plated at 1 × 106/mL in RPMI and treated
as per mentioned earlier. Cell culture supernatants were harvested
after indicated time points and frozen at −20°C until analysis. Sub-
sequently they were tested for the presence of IL-12p40 and IL-10
by ELISA (Biolegend, Sanquin respectively) according to manu-
facturer’s instructions, or properdin and fH using in-house specific
sandwich ELISAs [54, 55]. In short, the factor H ELISA plate was
coated with rabbit anti factor H and detection with rabbit anti fac-
tor H digoxigenin (DIG) followed by sheep anti-DIG horseradish
peroxidase. The properdin ELISA was performed by coating with
rabbit anti-human properdin followed by detection with rabbit
anti-human properdin DIG and sheep anti-DIG horseradish per-
oxidase. For both complement protein ELISA, ABTS was used as
chromogen with absorbance read at 415 nm.
Cell culture medium with 10% FCS unexposed to cells was
negative in all complement assays used.
RNA interference
DCs were transfected with 50 nM siRNA through the use of the
transfection reagent Lipofectamine 2000 (Life Technologies) and
were used for experiments 24 h after transfection. The following
SMARTpool siRNAs were used (Dharmacon): CFP, CFH and non-
targeting siRNA as a control. DC viability (PI staining) and target
protein specificity were assessed (Supporting Information Fig. 1).
Silencing of expression was verified by fP and fH ELISA.
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Statistical analysis
Statistical analysis was performed with Graph Pad Prism (Graph
Pad Software, San Diego, CA) using a one-tailed t-test. P-values 
0.05 were considered statistically significant.
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